In addition, another study on GC proposed an alternative mechanism: tumor-derived ADM activates the PI3K/AKT signaling pathway in the GC microenvironment, inducing the degranulation of tumor-associated mast cells to release IL-17A in a dose-dependent manner, thereby promoting GC cell proliferation and inhibiting GC cell apoptosis [72]. Here, IL17A is linked to neoplasm.